Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.

Ohno M, Matsuzaki J, Kawauchi J, Aoki Y, Miura J, Takizawa S, Kato K, Sakamoto H, Matsushita Y, Takahashi M, Miyakita Y, Ichimura K, Narita Y, Ochiya T.

JAMA Netw Open. 2019 Dec 2;2(12):e1916953. doi: 10.1001/jamanetworkopen.2019.16953.

PMID:
31808923
2.

Development and internal validation of a nomogram to predict perioperative complications after flexible ureteroscopy for renal stones in overnight ureteral catheterization cases.

Komeya M, Odaka H, Asano J, Asai T, Saigusa Y, Ogawa T, Yao M, Matsuzaki J.

World J Urol. 2019 Nov 29. doi: 10.1007/s00345-019-03023-y. [Epub ahead of print]

PMID:
31784774
3.

Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab.

Sudo K, Kato K, Matsuzaki J, Takizawa S, Aoki Y, Shoji H, Iwasa S, Honma Y, Takashima A, Sakamoto H, Naka T, Sekine S, Boku N, Ochiya T.

Jpn J Clin Oncol. 2019 Oct 15. pii: hyz146. doi: 10.1093/jjco/hyz146. [Epub ahead of print]

PMID:
31612917
4.

Brain metastasis-related microRNAs in patients with advanced breast cancer.

Sato J, Shimomura A, Kawauchi J, Matsuzaki J, Yamamoto Y, Takizawa S, Sakamoto H, Ohno M, Narita Y, Ochiya T, Tamura K.

PLoS One. 2019 Oct 11;14(10):e0221538. doi: 10.1371/journal.pone.0221538. eCollection 2019.

5.

Serum microRNA profile enables preoperative diagnosis of uterine leiomyosarcoma.

Yokoi A, Matsuzaki J, Yamamoto Y, Tate K, Yoneoka Y, Shimizu H, Uehara T, Ishikawa M, Takizawa S, Aoki Y, Kato K, Kato T, Ochiya T.

Cancer Sci. 2019 Dec;110(12):3718-3726. doi: 10.1111/cas.14215. Epub 2019 Nov 16.

6.

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease.

Yokoyama S, Yoshinaga T, Matsuzaki J, Suzuki H.

J Alzheimers Dis. 2019;71(4):1187-1199. doi: 10.3233/JAD-190305.

PMID:
31498121
7.

Transcriptomic Dissection of Hepatocyte Heterogeneity: Linking Ploidy, Zonation, and Stem/Progenitor Cell Characteristics.

Katsuda T, Hosaka K, Matsuzaki J, Usuba W, Prieto-Vila M, Yamaguchi T, Tsuchiya A, Terai S, Ochiya T.

Cell Mol Gastroenterol Hepatol. 2019 Sep 5;9(1):161-183. doi: 10.1016/j.jcmgh.2019.08.011. [Epub ahead of print]

8.

Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer.

Satomi-Tsushita N, Shimomura A, Matsuzaki J, Yamamoto Y, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Kato K, Shimizu C, Ochiya T, Tamura K.

PLoS One. 2019 Sep 4;14(9):e0222024. doi: 10.1371/journal.pone.0222024. eCollection 2019.

9.

Delayed M50/M100 evoked response component latency in minimally verbal/nonverbal children who have autism spectrum disorder.

Roberts TPL, Matsuzaki J, Blaskey L, Bloy L, Edgar JC, Kim M, Ku M, Kuschner ES, Embick D.

Mol Autism. 2019 Aug 15;10:34. doi: 10.1186/s13229-019-0283-3. eCollection 2019.

10.

Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes.

Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto-Vila M, Hosaka K, Takeuchi A, Saito Y, Ochiya T.

Elife. 2019 Aug 8;8. pii: e47313. doi: 10.7554/eLife.47313.

11.

10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.

Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T.

Digestion. 2019 Aug 6:1-7. doi: 10.1159/000501610. [Epub ahead of print]

PMID:
31387107
12.

Generation of functional human hepatocytes in vitro: current status and future prospects.

Yamaguchi T, Matsuzaki J, Katsuda T, Saito Y, Saito H, Ochiya T.

Inflamm Regen. 2019 Jul 2;39:13. doi: 10.1186/s41232-019-0102-4. eCollection 2019. Review.

13.

Abnormal Auditory Mismatch Fields in Children and Adolescents with 47,XYY Syndrome.

Matsuzaki J, Bloy L, Blaskey L, Miller J, Kuschner ES, Ku M, Dipiero M, Airey M, Edgar JC, Embick D, Ross JL, Roberts TPL.

Dev Neurosci. 2019;41(1-2):123-131. doi: 10.1159/000500799. Epub 2019 Jul 5.

PMID:
31280271
14.

Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.

Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, Cortes E, Wong L, Yan L, Long M, Miliotto A, Bateman NW, Lele SB, Chodon T, Koya RC, Yao S, Zhu Q, Conrads TP, Wang J, Maxwell GL, Lugade AA, Odunsi K.

J Immunother Cancer. 2019 Jun 20;7(1):156. doi: 10.1186/s40425-019-0629-6.

15.

Lesser suppression of response to bright visual stimuli and visual abnormality in children with autism spectrum disorder: a magnetoencephalographic study.

Aoki S, Kagitani-Shimono K, Matsuzaki J, Hanaie R, Nakanishi M, Tominaga K, Nagai Y, Mohri I, Taniike M.

J Neurodev Disord. 2019 Jun 14;11(1):9. doi: 10.1186/s11689-019-9266-0.

16.

Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells.

Tsugawa H, Kato C, Mori H, Matsuzaki J, Kameyama K, Saya H, Hatakeyama M, Suematsu M, Suzuki H.

Cell Mol Gastroenterol Hepatol. 2019;8(3):319-334. doi: 10.1016/j.jcmgh.2019.05.008. Epub 2019 May 27.

17.

Serum MicroRNA-Based Risk Prediction for Stroke.

Sonoda T, Matsuzaki J, Yamamoto Y, Sakurai T, Aoki Y, Takizawa S, Niida S, Ochiya T.

Stroke. 2019 Jun;50(6):1510-1518. doi: 10.1161/STROKEAHA.118.023648. Epub 2019 Apr 15.

PMID:
31136284
18.

Abnormal auditory mismatch fields are associated with communication impairment in both verbal and minimally verbal/nonverbal children who have autism spectrum disorder.

Matsuzaki J, Kuschner ES, Blaskey L, Bloy L, Kim M, Ku M, Edgar JC, Embick D, Roberts TPL.

Autism Res. 2019 Aug;12(8):1225-1235. doi: 10.1002/aur.2136. Epub 2019 May 28.

19.

Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.

Sudo K, Kato K, Matsuzaki J, Boku N, Abe S, Saito Y, Daiko H, Takizawa S, Aoki Y, Sakamoto H, Niida S, Takeshita F, Fukuda T, Ochiya T.

JAMA Netw Open. 2019 May 3;2(5):e194573. doi: 10.1001/jamanetworkopen.2019.4573. Erratum in: JAMA Netw Open. 2019 Jun 5;2(6):e197401.

20.

Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia.

Matsuzaki J, Tsugawa H, Kashiwazaki Y, Mori H, Yamamoto Y, Kameyama H, Masaoka T, Kanai T, Suzuki H.

Cell Mol Gastroenterol Hepatol. 2019;8(2):295-297.e6. doi: 10.1016/j.jcmgh.2019.05.004. Epub 2019 May 18. No abstract available.

21.

Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma.

Matsuzaki J, Suzuki H, Shimoda M, Mori H, Fukuhara S, Miyoshi S, Masaoka T, Iwao Y, Kanai Y, Kanai T.

United European Gastroenterol J. 2019 Mar;7(2):250-260. doi: 10.1177/2050640618817689. Epub 2018 Dec 3.

22.

Development of a small car-mounted magnetic resonance imaging system for human elbows using a 0.2 T permanent magnet.

Nakagomi M, Kajiwara M, Matsuzaki J, Tanabe K, Hoshiai S, Okamoto Y, Terada Y.

J Magn Reson. 2019 Jul;304:1-6. doi: 10.1016/j.jmr.2019.04.017. Epub 2019 Apr 27.

PMID:
31063952
23.

Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.

Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, Arai E, Sugiyama Y, Matsuzaki J, Uchida R, Yoshikawa N, Furukawa R, Saito H.

Cell Rep. 2019 Apr 23;27(4):1265-1276.e4. doi: 10.1016/j.celrep.2019.03.088.

24.

White Matter Tract-Cognitive Relationships in Children with High-Functioning Autism Spectrum Disorder.

Kato Y, Kagitani-Shimono K, Matsuzaki J, Hanaie R, Yamamoto T, Tominaga K, Watanabe Y, Mohri I, Taniike M.

Psychiatry Investig. 2019 Mar;16(3):220-233. doi: 10.30773/pi.2019.01.16. Epub 2019 Mar 21.

25.

Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.

Chuma M, Toyoda H, Matsuzaki J, Saito Y, Kumada T, Tada T, Kaneoka Y, Maeda A, Yokoo H, Ogawa K, Kamiyama T, Taketomi A, Matsuno Y, Yazawa K, Takeda K, Kunisaki C, Ogushi K, Moriya S, Hara K, Nozaki A, Kondo M, Fukuda H, Numata K, Tanaka K, Maeda S, Sakamoto N.

Hepatol Res. 2019 Jul;49(7):810-822. doi: 10.1111/hepr.13338. Epub 2019 May 23.

PMID:
30920086
26.

A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.

Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T.

Nat Commun. 2019 Mar 21;10(1):1299. doi: 10.1038/s41467-019-09143-8.

27.

Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.

Urabe F, Matsuzaki J, Yamamoto Y, Kimura T, Hara T, Ichikawa M, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Egawa S, Fujimoto H, Ochiya T.

Clin Cancer Res. 2019 May 15;25(10):3016-3025. doi: 10.1158/1078-0432.CCR-18-2849. Epub 2019 Feb 26.

PMID:
30808771
28.

Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.

Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB, Matsuzaki J, Koya RC, Blom AM, McLeish KR, Qu J, Ram S, Moysich KB, Abrams SI, Odunsi K, Zsiros E, Segal BH.

JCI Insight. 2019 Mar 7;4(5). pii: 122311. doi: 10.1172/jci.insight.122311. eCollection 2019 Mar 7.

29.

A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.

Matsuzaki J, Tsuji T, Chodon T, Ryan C, Koya RC, Odunsi K.

J Immunother Cancer. 2019 Jan 9;7(1):7. doi: 10.1186/s40425-018-0467-y.

30.

Abnormal auditory mismatch fields in adults with autism spectrum disorder.

Matsuzaki J, Ku M, Berman JI, Blaskey L, Bloy L, Chen YH, Dell J, Edgar JC, Kuschner ES, Liu S, Saby J, Brodkin ES, Roberts TPL.

Neurosci Lett. 2019 Apr 17;698:140-145. doi: 10.1016/j.neulet.2018.12.043. Epub 2018 Dec 29.

PMID:
30599264
31.

Aberrant Cerebellar-Cerebral Functional Connectivity in Children and Adolescents With Autism Spectrum Disorder.

Hanaie R, Mohri I, Kagitani-Shimono K, Tachibana M, Matsuzaki J, Hirata I, Nagatani F, Watanabe Y, Katayama T, Taniike M.

Front Hum Neurosci. 2018 Nov 13;12:454. doi: 10.3389/fnhum.2018.00454. eCollection 2018.

32.

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Shiino S, Matsuzaki J, Shimomura A, Kawauchi J, Takizawa S, Sakamoto H, Aoki Y, Yoshida M, Tamura K, Kato K, Kinoshita T, Kitagawa Y, Ochiya T.

Clin Cancer Res. 2019 Mar 15;25(6):1817-1827. doi: 10.1158/1078-0432.CCR-18-1414. Epub 2018 Nov 27.

PMID:
30482779
33.

Abnormal cortical activation during silent reading in adolescents with autism spectrum disorder.

Ogawa R, Kagitani-Shimono K, Matsuzaki J, Tanigawa J, Hanaie R, Yamamoto T, Tominaga K, Hirata M, Mohri I, Taniike M.

Brain Dev. 2019 Mar;41(3):234-244. doi: 10.1016/j.braindev.2018.10.013. Epub 2018 Nov 15.

PMID:
30448302
34.

Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.

Miyoshi S, Tsugawa H, Matsuzaki J, Hirata K, Mori H, Saya H, Kanai T, Suzuki H.

Anticancer Res. 2018 Nov;38(11):6163-6170. doi: 10.21873/anticanres.12969.

PMID:
30396933
35.

Circulating miRNA panels for specific and early detection in bladder cancer.

Usuba W, Urabe F, Yamamoto Y, Matsuzaki J, Sasaki H, Ichikawa M, Takizawa S, Aoki Y, Niida S, Kato K, Egawa S, Chikaraishi T, Fujimoto H, Ochiya T.

Cancer Sci. 2019 Jan;110(1):408-419. doi: 10.1111/cas.13856. Epub 2018 Dec 12.

36.

Integrated extracellular microRNA profiling for ovarian cancer screening.

Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T.

Nat Commun. 2018 Oct 17;9(1):4319. doi: 10.1038/s41467-018-06434-4.

37.

CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobacter pylori CagA-degraded autophagy.

Tsugawa H, Mori H, Matsuzaki J, Sato A, Saito Y, Imoto M, Suematsu M, Suzuki H.

Autophagy. 2019 Feb;15(2):242-258. doi: 10.1080/15548627.2018.1515530. Epub 2018 Sep 10.

38.

Abnormal cortical activation during an auditory word comprehension task in benign childhood epilepsy with centrotemporal spikes: A magnetoencephalographic study.

Kagitani-Shimono K, Kato Y, Hanaie R, Matsuzaki J, Tanigawa J, Iwatani Y, Azuma J, Taniike M.

Epilepsy Behav. 2018 Oct;87:159-166. doi: 10.1016/j.yebeh.2018.05.035. Epub 2018 Aug 16.

PMID:
30120072
39.

Extracellular microRNAs and oxidative stress in liver injury: a systematic mini review.

Matsuzaki J, Ochiya T.

J Clin Biochem Nutr. 2018 Jul;63(1):6-11. doi: 10.3164/jcbn.17-123. Epub 2018 Apr 11. Review.

40.

Absence of high-risk stigmata predicts good prognosis even in severely anemic patients with suspected acute upper gastrointestinal bleeding.

Horibe M, Ogura Y, Matsuzaki J, Kaneko T, Yokota T, Okawa O, Nakatani Y, Iwasaki E, Nishizawa T, Hosoe N, Masaoka T, Yahagi N, Namiki S, Kanai T.

United European Gastroenterol J. 2018 Jun;6(5):684-690. doi: 10.1177/2050640618764161. Epub 2018 Apr 10.

41.
42.

Comparison of Outcomes between Two Methods to Extract Stone Fragments during Flexible Ureteroscopic Lithotripsy.

Tabei T, Ito H, Kobayashi K, Kawahara T, Matsuzaki J.

Biomed Res Int. 2018 May 30;2018:4526721. doi: 10.1155/2018/4526721. eCollection 2018.

43.

Atypical auditory language processing in adolescents with autism spectrum disorder.

Tanigawa J, Kagitani-Shimono K, Matsuzaki J, Ogawa R, Hanaie R, Yamamoto T, Tominaga K, Nabatame S, Mohri I, Taniike M, Ozono K.

Clin Neurophysiol. 2018 Sep;129(9):2029-2037. doi: 10.1016/j.clinph.2018.05.014. Epub 2018 Jun 8.

PMID:
29934264
44.

Burden of impaired sleep quality on work productivity in functional dyspepsia.

Matsuzaki J, Suzuki H, Togawa K, Yamane T, Mori H, Komori T, Masaoka T, Kanai T.

United European Gastroenterol J. 2018 Apr;6(3):398-406. doi: 10.1177/2050640617726466. Epub 2017 Aug 7.

45.

Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens.

Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T.

United European Gastroenterol J. 2018 Apr;6(3):391-397. doi: 10.1177/2050640617737215. Epub 2017 Oct 8.

46.

Outcome of flexible ureteroscopy for renal stone with overnight ureteral catheterization: a propensity score-matching analysis.

Komeya M, Usui K, Asai T, Ogawa T, Taguri M, Kataoka K, Yao M, Matsuzaki J.

World J Urol. 2018 Nov;36(11):1871-1876. doi: 10.1007/s00345-018-2328-1. Epub 2018 May 14.

PMID:
29761227
47.

Gastric cancer: evidence boosts Helicobacter pylori eradication.

Suzuki H, Matsuzaki J.

Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):458-460. doi: 10.1038/s41575-018-0023-8. No abstract available.

PMID:
29713024
48.

Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.

Tsuji T, Yoneda A, Matsuzaki J, Miliotto A, Ryan C, Koya RC, Odunsi K.

Cancer Immunol Res. 2018 May;6(5):594-604. doi: 10.1158/2326-6066.CIR-17-0434. Epub 2018 Mar 27.

49.

Association between single nucleotide polymorphisms in estrogen receptor 1/2 genes and symptomatic severity of autism spectrum disorder.

Doi H, Fujisawa TX, Iwanaga R, Matsuzaki J, Kawasaki C, Tochigi M, Sasaki T, Kato N, Shinohara K.

Res Dev Disabil. 2018 Nov;82:20-26. doi: 10.1016/j.ridd.2018.02.014. Epub 2018 Mar 8.

PMID:
29526366
50.

A new prediction model for operative time of flexible ureteroscopy with lithotripsy for the treatment of renal stones.

Kuroda S, Ito H, Sakamaki K, Tabei T, Kawahara T, Fujikawa A, Makiyama K, Yao M, Uemura H, Matsuzaki J.

PLoS One. 2018 Feb 13;13(2):e0192597. doi: 10.1371/journal.pone.0192597. eCollection 2018.

Supplemental Content

Loading ...
Support Center